Larry Rand, MD

Perinatologist

Dr. Larry Rand, director of Perinatal Services at the UCSF Fetal Treatment Center, is an obstetrician and gynecologist who specializes in high-risk pregnancy and maternal-fetal medicine, with a special interest in fetal disorders. He counsels and coordinates care and participates in prenatal diagnosis, specializing in procedures such as chorionic villus sampling (CVS), amniocentesis, intra-uterine transfusion and fetal biopsies, as well as interventions such as lung and bladder shunt placements, fetal bladder taps and multi-fetal pregnancy reduction. In addition, Rand cares for patients during labor and delivery.

In his research, he has a special interest in complicated monochorionic twin pregnancies. He has presented research in the fetal treatment community internationally and was nominated for a Young Investigator Excellence in Research Award at the 2009 American Institute for Ultrasound Medicine national meeting. He holds leadership positions at the American College of Obstetrics and Gynecology, and serves on the Patient Safety and Quality Assurance Committee. He travels to West Africa and Central America several times a year to perform surgery and provide high-risk obstetric care to patients with limited access, and to create sustainable health programs in these countries.

Read a Q&A with Rand.

Clinics

Fetal Treatment Center
1855 Fourth St., Second Floor, Room A-2432
San Francisco, CA 94158
Phone: (800) 793-3887
Fax: (415) 502-0660

Hours: Monday to Friday
8 a.m. - 5 p.m.

Prenatal Diagnostic Center
1825 Fourth St., Third Floor
San Francisco, CA 94158
Phone: (415) 476-4080
Fax: (415) 353-4077

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Academic Title

Associate Professor

More about Larry Rand

Additional Languages

German

Education

Harvard School of Medicine 1999

Residencies

Brigham and Women's Hospital, Obstetrics and Gynecology 2003

Fellowships

Mount Sinai Hospital, Maternal-Fetal Medicine 2006

Selected Research and Publications

  1. Steurer MA, Oltman S, Baer RJ, Feuer S, Liang L, Paynter RA, Rand L, Ryckman KK, Keller RL, Jelliffe-Pawlowski LL. Altered metabolites in newborns with persistent pulmonary hypertension. Pediatr Res. 2018 Jun 12.
  2. Jelliffe-Pawlowski LL, Rand L, Bedell B, Baer RJ, Oltman SP, Norton ME, Shaw GM, Stevenson DK, Murray JC, Ryckman KK. Prediction of preterm birth with and without preeclampsia using mid-pregnancy immune and growth-related molecular factors and maternal characteristics. J Perinatol. 2018 May 24.
  3. Oltman SP, Rogers EE, Baer RJ, Anderson JG, Steurer MA, Pantell MS, Partridge JC, Rand L, Ryckman KK, Jelliffe-Pawlowski LL. Initial Metabolic Profiles Are Associated with 7-Day Survival among Infants Born at 22-25 Weeks of Gestation. J Pediatr. 2018 Apr 13.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.